Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Ramosetron on QTc Interval During Prostatectomy
NCT03232125Completed
- Sponsor
- Yonsei University
- Start
- Aug 2017
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in postoperative nausea and vomiting (PONV) comparing Ramosetron group with Placebo group (2 arms). Primary endpoint: Maximum change of Heart Rate-corrected QT (QTc) interval. Started Aug 2017; status: completed.
02
Drugs
ramosetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT03232125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03232125.